Clene, Inc. (CLNN)
4.08
+0.06
(+1.49%)
USD |
NASDAQ |
Oct 02, 16:00
4.04
-0.04
(-0.98%)
After-Hours: 20:00
Clene Market Cap : 52.14M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 52.14M |
| October 01, 2026 | 51.37M |
| September 30, 2026 | 52.14M |
| September 29, 2026 | 52.39M |
| September 28, 2026 | 51.88M |
| September 25, 2026 | 54.95M |
| September 24, 2026 | 53.80M |
| September 23, 2026 | 54.82M |
| September 22, 2026 | 55.97M |
| September 21, 2026 | 58.01M |
| September 18, 2026 | 55.59M |
| September 17, 2026 | 53.03M |
| September 16, 2026 | 49.32M |
| September 15, 2026 | 51.37M |
| September 14, 2026 | 41.91M |
| September 11, 2026 | 45.62M |
| September 10, 2026 | 46.64M |
| September 09, 2026 | 47.54M |
| September 08, 2026 | 46.26M |
| September 04, 2026 | 49.20M |
| September 03, 2026 | 51.05M |
| September 02, 2026 | 53.16M |
| September 01, 2026 | 52.45M |
| August 31, 2026 | 54.69M |
| August 28, 2026 | 54.05M |
| Date | Value |
|---|---|
| August 27, 2026 | 57.12M |
| August 26, 2026 | 59.42M |
| August 25, 2026 | 56.74M |
| August 24, 2026 | 56.67M |
| August 21, 2026 | 55.20M |
| August 20, 2026 | 55.84M |
| August 19, 2026 | 53.54M |
| August 18, 2026 | 52.26M |
| August 17, 2026 | 53.67M |
| August 14, 2026 | 52.90M |
| August 13, 2026 | 53.54M |
| August 12, 2026 | 52.01M |
| August 11, 2026 | 55.84M |
| August 10, 2026 | 60.78M |
| August 07, 2026 | 62.19M |
| August 06, 2026 | 62.90M |
| August 05, 2026 | 63.37M |
| August 04, 2026 | 62.19M |
| August 03, 2026 | 61.13M |
| July 31, 2026 | 59.07M |
| July 30, 2026 | 59.36M |
| July 29, 2026 | 55.59M |
| July 28, 2026 | 58.77M |
| July 27, 2026 | 64.31M |
| July 24, 2026 | 63.48M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovelStem International Corp. | 0.4687M |
| Brainstorm Cell Therapeutics, Inc. | 10.26M |
| Summit Therapeutics, Inc. | 13.29B |
| Kezar Life Sciences, Inc. | 53.76M |
| Protara Therapeutics, Inc. | 159.53M |
Market Cap Related Metrics
| PS Ratio | 231.93 |
| PEG Ratio | -0.0331 |
| Price | 4.08 |
| Earnings Yield | -86.09% |
| PEGY Ratio | -0.0331 |